Navigation Links
MannKind to Present at Upcoming Conferences
Date:6/16/2008

VALENCIA, Calif., June 16 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.

-- 18th Annual Wachovia Nantucket Equity Conference on Monday, June 23,

2008 at 11:45 AM (Eastern Time) at The White Elephant in Nantucket

Island, Massachusetts

-- 2nd Annual Jefferies Healthcare Conference on Thursday, June 26, 2008

at 2:00 PM (Eastern Time) in New York

Interested parties can access a link to the live web cast of the presentations in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of each presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.


'/>"/>
SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. MannKind to Present at the UBS Global Life Sciences Conference
2. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
3. MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
4. MannKind to Present at the Piper Jaffray Healthcare Conference
5. MannKind to Present at the Wachovia 2008 Healthcare Conference
6. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
8. MannKind Corporation Response to Recent Market Events
9. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
10. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
11. MannKind to Present at the Morgan Stanley Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--DowAgroSciencesCanadaa...divisionofThompsonsLimitedofBlenheim,Ontario.Thead...s,currentseedsbusinessasthecompanyanticipatesthein...encesHerbicideTolerantTraitTechnologyincornin2012...., "Thisacquisitionbringstogethertwostrongprogres...
(Date:11/24/2009)...rstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )w...ecember1stat1:45PMGMTinLondon,7:45AMUS/CST.Interes...ernetavailableat http://inve s tor.sig m a a...essthisfile. ,, AboutSigma-Aldrich: Sigma-Al....Itschemicalandbiochemicalproductsandkitsareusedin...
(Date:11/24/2009)...PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq...day"motionsbytheU.S.BankruptcyCourtfortheDistricto...edavoluntarypetitionfor,reliefunderChapter11oftheU..., TheordersissuedbytheBankruptcyCourtallowthe...pter11proceedings.Inparticular,the,companyreceived...
(Date:11/24/2009)...wire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abi...cializingnovelpainmanagementtherapies,announcedtod...icer,isscheduledtopresentatthe21stAnnualPiperJaffr...heNewYorkPalaceHotelinNewYork,NewYork. ,, Mr.Di...lbeavailabletorespondtoquestionsduringthepresentat...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...a., Dec. 9 First Coast Service Options (FCSO) has...r in Medicare reimbursement solutions, to support ...nters for Medicare & Medicaid Services (CMS). ...e reimbursement disputes beginning Jan. 1, 2009 be...ring Medicare Private Fee-for-Service (PFFS) plans...
.... 9 Delcath Systems, Inc. (Nasdaq: DCTH ) today.... to Delcath,s Board of Directors. Dr. Stoll is E...(Amex: COR ), a biotechnology company specializi...rders. , , (Logo: http://www.newscom.com/...r to joining Cortex, Dr. Stoll worked as a consult...
...n., Dec. 9 Soliris(R) (eculizumab),a terminal com...cals, Inc.,(Nasdaq: ALXN ), was observed by inve... undiagnosed blood clots and inflammation in patie...Soliris was observed to reduce indicators of,pulmo...roxysmal nocturnal,hemoglobinuria (PNH), according...
Other Biology Technology:FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract 2Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors 2Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors 3Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 2Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 3Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 4Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 5Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 6Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 7Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH 8
(Date:11/24/2009)...s have crystallised a protein that may help gut ba...tein could be used by probiotic producers to ident...to people. , "Probiotics need to interact with ce...d if they attach to surfaces in the gut they are m...eir activity," says Dr Nathalie Juge from the Inst...
(Date:11/24/2009)...OUGE Antarctica has long held secrets of the eart...cently, there has been very little information on ...es of ice for millions of years. Now, a team of re...ave been funded to the tune of $10 million dollars...t to the bottom of things literally. These scient...
(Date:11/23/2009)...n, D.C. The community-associated strain of the de...sistant to most common antibioticsposes a far grea...ing its way into hospitals, according to a study i...ses . , The new threat is easily picked up in f...nd has increased the overall burden of MRSA within...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2MUSC Earns 2420 Million Award From National Institutes of Health 51650 1MUSC Earns 2420 Million Award From National Institutes of Health 51650 2MUSC Earns 2420 Million Award From National Institutes of Health 51650 3Econo Lodge Hotels Team with Strikeouts For Troops to Help Consumers Send Personal Thank You Notes to U S Armed Forces 51647 1Econo Lodge Hotels Team with Strikeouts For Troops to Help Consumers Send Personal Thank You Notes to U S Armed Forces 51647 2Econo Lodge Hotels Team with Strikeouts For Troops to Help Consumers Send Personal Thank You Notes to U S Armed Forces 51647 3New 3A Interventional radiology coding users guide 51644 1New 3A Interventional radiology coding users guide 51644 2
...bnail, the cubic insect-like robots or ,insbots, a...pean Commission,s Future and Emerging Technologies...ect Leurre, the insbots are fitted with two motors... processors, a light-sensing camera and an array o... a small experimental area with a maze of curved w...
...covered a new mechanism used by cells ?and manipul...tain essential proteins, including some involved i...NA helicase A (RHA), which is made by the cell. ,...versity Comprehensive Cancer Center ?Arthur G. Jam...Institute and the OSU College of Veterinary Medici...
...boratory techniques may provide biology researcher... blocking the activity of targeted genes. RNA inte... in studying how genes function in normal biologic...nal of Immunological Methods, published online on ...ital of Philadelphia combined laboratory technolog...
Other Biology News:Robots manipulating animal behaviour 2Robots manipulating animal behaviour 3Scientists discover new regulating mechanism in cells 2Scientists discover new regulating mechanism in cells 3Interfering RNA silences genes in 'slippery' immune cells 2Interfering RNA silences genes in 'slippery' immune cells 3
...he Genome Sequencer 20 System revolutionizes DNA s... parallel fashion. The Genome Sequencer 20 System...and consumables for library construction, amplific...ng and de novo assembly The instrument is the c...
...astman Kodak Companys Molecular Imaging Systems gr...ion 4000 Digital Imaging Systems, featuring high r...ensive fluorescence, luminescence, radiographic an...llion pixel CCD and 10x optical zoom lens provides...
...t has been demonstrated that oxidative stress is i...isease, and cancer. Oxidative stress is the condit...and physiological antioxidants exist leading to th...se to oxidative stress is through several antioxid...
Neurological Profile from Novascreen-a Caliper Life Sciences Company
Biology Products: